ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 189 filers reported holding ARRAY BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $139,239,000 | +106.9% | 3,005,394 | +8.9% | 0.03% | +100.0% |
| Q1 2019 | $67,306,000 | -5.3% | 2,760,761 | -44.7% | 0.02% | +54.5% |
| Q4 2018 | $71,098,000 | +101.6% | 4,989,452 | +115.0% | 0.01% | +10.0% |
| Q3 2018 | $35,270,000 | -3.6% | 2,320,411 | +6.4% | 0.01% | -9.1% |
| Q2 2018 | $36,589,000 | +13.1% | 2,180,551 | +10.0% | 0.01% | 0.0% |
| Q1 2018 | $32,339,000 | +35.3% | 1,981,611 | +6.1% | 0.01% | +37.5% |
| Q4 2017 | $23,906,000 | +8.9% | 1,867,750 | +4.7% | 0.01% | 0.0% |
| Q3 2017 | $21,943,000 | +74.9% | 1,784,045 | +19.0% | 0.01% | +60.0% |
| Q2 2017 | $12,548,000 | -10.4% | 1,499,178 | -4.3% | 0.01% | -16.7% |
| Q1 2017 | $14,000,000 | +9.7% | 1,566,152 | +7.8% | 0.01% | 0.0% |
| Q4 2016 | $12,767,000 | +98.5% | 1,452,520 | +52.4% | 0.01% | +100.0% |
| Q3 2016 | $6,433,000 | +98.4% | 953,180 | +4.6% | 0.00% | +50.0% |
| Q2 2016 | $3,242,000 | +24.4% | 910,869 | +3.0% | 0.00% | +100.0% |
| Q1 2016 | $2,607,000 | -40.4% | 883,950 | -14.7% | 0.00% | -50.0% |
| Q4 2015 | $4,373,000 | +10.7% | 1,036,436 | +19.6% | 0.00% | 0.0% |
| Q3 2015 | $3,950,000 | -32.4% | 866,247 | +6.9% | 0.00% | -33.3% |
| Q2 2015 | $5,840,000 | -1.8% | 810,079 | +0.3% | 0.00% | 0.0% |
| Q1 2015 | $5,950,000 | +80.8% | 807,374 | +16.0% | 0.00% | +50.0% |
| Q4 2014 | $3,291,000 | +58.8% | 695,843 | +19.8% | 0.00% | +100.0% |
| Q3 2014 | $2,073,000 | -20.3% | 580,949 | +1.9% | 0.00% | -50.0% |
| Q2 2014 | $2,600,000 | -1.8% | 570,348 | +1.2% | 0.00% | 0.0% |
| Q1 2014 | $2,649,000 | -0.5% | 563,781 | +6.1% | 0.00% | 0.0% |
| Q4 2013 | $2,661,000 | -17.7% | 531,183 | +2.2% | 0.00% | -33.3% |
| Q3 2013 | $3,233,000 | +49.0% | 519,794 | +8.7% | 0.00% | +50.0% |
| Q2 2013 | $2,170,000 | – | 478,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |